Bracco Diagnostics, Inc has been given the go ahead by the U.S. Food and Drug Administration to temporarily import Iomeron (iomeprol injection) into the U.S. market amid the ongoing iodinated contrast media shortage. 

On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

The proposed payment increase of 2.7% doesn't make up for sequestration cuts, inflation, and other factors hitting hospitals, medical groups say. 

Some patients with certain autoimmune diseases are finding it difficult to obtain their prescriptions for methotrexate as a result of changing abortion care laws.

Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling. 

A retrospective analysis of cross-sectional venograms shows only 4.5% of a teaching hospital’s COVID-vaccinated patients had a clotting condition in early 2021. Meanwhile the rate for the unvaccinated was 10.1%.

The American Heart Association and Association of Black Cardiologists announced the winners of a six-month data challenge, describing health equity as "one of the most pressing areas in healthcare.”

When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.